Kyung Dong Pharmaceutical Co. Ltd (011040) - Net Assets

Latest as of December 2025: ₩228.87 Billion KRW ≈ $155.10 Million USD

Based on the latest financial reports, Kyung Dong Pharmaceutical Co. Ltd (011040) has net assets worth ₩228.87 Billion KRW (≈ $155.10 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩321.90 Billion ≈ $218.14 Million USD) and total liabilities (₩93.02 Billion ≈ $63.04 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check financial resilience of Kyung Dong Pharmaceutical Co. Ltd to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	₩228.87 Billion
% of Total Assets	71.1%
Annual Growth Rate	3.03%
5-Year Change	-11.91%
10-Year Change	9.03%
Growth Volatility	6.94

Kyung Dong Pharmaceutical Co. Ltd - Net Assets Trend (2011–2025)

This chart illustrates how Kyung Dong Pharmaceutical Co. Ltd's net assets have evolved over time, based on quarterly financial data. Also explore 011040 total asset value for the complete picture of this company's asset base.

Annual Net Assets for Kyung Dong Pharmaceutical Co. Ltd (2011–2025)

The table below shows the annual net assets of Kyung Dong Pharmaceutical Co. Ltd from 2011 to 2025. For live valuation and market cap data, see 011040 company net worth.

Year	Net Assets	Change
2025-12-31	₩228.87 Billion ≈ $155.10 Million	+4.00%
2024-12-31	₩220.06 Billion ≈ $149.13 Million	-3.68%
2023-12-31	₩228.48 Billion ≈ $154.84 Million	-11.17%
2022-12-31	₩257.20 Billion ≈ $174.30 Million	-1.01%
2021-12-31	₩259.82 Billion ≈ $176.08 Million	-0.90%
2020-12-31	₩262.19 Billion ≈ $177.68 Million	+15.65%
2019-12-31	₩226.71 Billion ≈ $153.64 Million	+7.08%
2018-12-31	₩211.72 Billion ≈ $143.48 Million	-4.18%
2017-12-31	₩220.95 Billion ≈ $149.74 Million	+5.25%
2016-12-31	₩209.93 Billion ≈ $142.26 Million	+2.34%
2015-12-31	₩205.14 Billion ≈ $139.02 Million	+7.72%
2014-12-31	₩190.43 Billion ≈ $129.05 Million	+12.66%
2013-12-31	₩169.03 Billion ≈ $114.55 Million	+9.93%
2012-12-31	₩153.76 Billion ≈ $104.20 Million	+2.09%
2011-12-31	₩150.62 Billion ≈ $102.07 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Kyung Dong Pharmaceutical Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 19361453703000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	₩193.61 Billion	84.79%
Other Components	₩34.74 Billion	15.21%
Total Equity	₩228.36 Billion	100.00%

Kyung Dong Pharmaceutical Co. Ltd Competitors by Market Cap

The table below lists competitors of Kyung Dong Pharmaceutical Co. Ltd ranked by their market capitalization.

Company	Market Cap
Shine Justice Ltd AU:SHJ	$89.89 Million
KAISA GROUP HLDGS F:KG5	$89.89 Million
Apex Biotechnology Corp TW:1733	$89.90 Million
Pinar Sut Mamulleri Sanayi AS IS:PNSUT	$89.93 Million
Bathurst Resources Ltd F:B0R	$89.81 Million
Intertek Group PLC LSE:ITRK	$89.74 Million
Q.BEYOND AG NA O.N. KONV. XETRA:QBY0	$89.70 Million
CDON AB ST:CDON	$89.70 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Kyung Dong Pharmaceutical Co. Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 220,060,755,990 to 228,357,460,080, a change of 8,296,704,090 (3.8%).
Net income of 8,528,662,000 contributed positively to equity growth.
Dividend payments of 8,082,531,000 reduced retained earnings.
Other factors increased equity by 7,850,573,090.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	₩8.53 Billion	+3.73%
Dividends Paid	₩8.08 Billion	-3.54%
Other Changes	₩7.85 Billion	+3.44%
Total Change	₩-	3.77%

Book Value vs Market Value Analysis

This analysis compares Kyung Dong Pharmaceutical Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.67x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2016-12-31	₩8926.12	₩5640.00	x
2017-12-31	₩9371.12	₩5640.00	x
2018-12-31	₩8941.38	₩5640.00	x
2019-12-31	₩9574.44	₩5640.00	x
2020-12-31	₩9461.29	₩5640.00	x
2021-12-31	₩9540.40	₩5640.00	x
2022-12-31	₩9468.64	₩5640.00	x
2023-12-31	₩8409.41	₩5640.00	x
2024-12-31	₩8168.01	₩5640.00	x
2025-12-31	₩8470.12	₩5640.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Kyung Dong Pharmaceutical Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 3.73%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 4.35%
• Asset Turnover: 0.61x
• Equity Multiplier: 1.41x
Recent ROE (3.73%) is below the historical average (6.02%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2011	13.47%	15.94%	0.69x	1.23x	₩5.23 Billion
2012	5.34%	6.60%	0.66x	1.23x	₩-7.17 Billion
2013	11.13%	14.17%	0.66x	1.18x	₩1.91 Billion
2014	12.89%	16.00%	0.67x	1.20x	₩5.49 Billion
2015	6.89%	9.30%	0.65x	1.14x	₩-6.38 Billion
2016	8.39%	11.10%	0.67x	1.14x	₩-3.38 Billion
2017	9.27%	11.52%	0.71x	1.14x	₩-1.62 Billion
2018	2.48%	2.92%	0.70x	1.22x	₩-15.93 Billion
2019	8.88%	11.40%	0.61x	1.27x	₩-2.54 Billion
2020	4.75%	7.17%	0.60x	1.11x	₩-13.76 Billion
2021	4.88%	7.13%	0.61x	1.12x	₩-13.31 Billion
2022	4.73%	6.66%	0.59x	1.21x	₩-13.56 Billion
2023	-9.08%	-12.73%	0.56x	1.28x	₩-43.53 Billion
2024	2.49%	2.82%	0.64x	1.38x	₩-16.54 Billion
2025	3.73%	4.35%	0.61x	1.41x	₩-14.31 Billion

Industry Comparison

This section compares Kyung Dong Pharmaceutical Co. Ltd's net assets metrics with peer companies in the Pharmaceuticals industry.

Industry Context

Industry: Pharmaceuticals
Average net assets among peers: $68,087,913,901
Average return on equity (ROE) among peers: -1.58%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Kyung Dong Pharmaceutical Co. Ltd (011040)	₩228.87 Billion	13.47%	0.41x	$89.89 Million
Sam Chun Dang Pharm. Co. Ltd (000250)	$86.63 Billion	1.55%	0.41x	$6.03 Billion
DongKoo Bio&Pharma Co. Ltd (006620)	$102.11 Billion	6.48%	0.69x	$33.52 Million
NatureCell Co.Ltd (007390)	$-16.60 Million	0.00%	0.00x	$688.81 Million
Sam-A Pharm. Co. Ltd (009300)	$79.92 Billion	4.39%	0.39x	$68.66 Million
WooGene B&G Co. Ltd (018620)	$22.14 Billion	0.79%	1.63x	$13.13 Million
Oscotec Inc (039200)	$94.72 Billion	-25.63%	0.40x	$990.30 Million
EstechPharma Co. Ltd (041910)	$115.63 Billion	3.31%	0.05x	$59.21 Million
Komipharm International Co. Ltd (041960)	$76.13 Billion	-8.60%	0.75x	$380.81 Million
Eagle Veterinary Technology Co.Ltd (044960)	$35.53 Billion	3.47%	0.29x	$34.35 Million

About Kyung Dong Pharmaceutical Co. Ltd

KQ:011040 Korea Pharmaceuticals

Market Cap

$89.89 Million

₩132.64 Billion KRW

Market Cap Rank

#19604 Global

#1102 in Korea

Share Price

₩5640.00

Change (1 day)

+0.36%

52-Week Range

₩5290.00 - ₩6200.00

All Time High

₩14206.86